T1	intervention 0 10	HydrosorbÂ®
T2	control 18 45	control (water based spray)
T3	condition 67 94	radio-induced skin toxicity
T4	eligibility 273 372	patients (pts) treated for early stage breast cancer (BC) with normo fractionated radiotherapy (RT)
T5	outcome-Measure 481 504	local treatment failure
T6	outcome-Measure 643 673	evaluation of skin colorimetry
T7	outcome-Measure 675 679	pain
T8	outcome-Measure 681 696	quality of life
T9	No-of-participants 698 723	Two-hundred seventy-eight
T10	No-of-participants 754 757	186
T11	outcome 798 808	"failures"
T12	intervention-value 795 797	60
T13	control-value 836 838	62
T14	outcome 975 1007	reduction of colorimetric levels
T15	intervention-value 1116 1127	Forty-eight
T16	outcome 1165 1171	VAS >2
T17	control-value 1179 1181	51
T18	intervention-value 1211 1214	34%
T19	control-value 1219 1222	38%
T20	outcome 1261 1278	reduction of pain
